Status:
COMPLETED
BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Hip Fracture
Eligibility:
FEMALE
65+ years
Phase:
NA
Brief Summary
The major goals of this study are: 1. To conduct an intervention development study to evaluate the feasibility of implementing an exercise intervention for reduction losses in bone mineral density, m...
Detailed Description
Hip fracture is a major public health problem, with striking consequences for the older patient, her family and the health care system. More than 350,000 persons over age 65 will fracture a hip in the...
Eligibility Criteria
Inclusion
- Hip fracture
Exclusion
- Male
- Under 65 years old
- Non-surgical repair of hip fracture
- Non-community dwelling
- Fractured more than 72 hours before admission to the hospital
- Pathologic fracture
- Resides more than 70 miles from the hospital of admission
- Recent diagnosis (in past 6 months) of angina or myocardial infarction
- Myocardial infarction or stroke concurrent with hip fracture
- Diagnosis of ventricular arrhythmia, third degree heart block, atrial fibrillation or if vital signs equal heart less than 60 or greater than 100
- Active or suspected myocarditis or pericarditis in the past year
- Recent (within past 6 months) deep venous thrombosis or intracardiac thrombi
- Persistent pulmonary edema during hospitalization
- Poorly controlled blood pressure w/ resting systolic greater than 180 mm Hg or resting diastolic greater than 100 mm Hg (3 or more readings with 24- hour period)
- Presence of ventricular aneurysm
- Paget's Disease
- Diabetes--blood sugar consistently greater than 300
- Diagnosis of thyrotoxicosis or myxedema within past year
- Any diagnosis of hyperparathyroidism, hypoparathyroidism, or osteomalacia
- Parkinson's, multiple sclerosis, or ALS (Lou Gehrig's disease)
- New (past 6 months) onset seizure disorder or seizure within the past 6 months
- Diagnosis of schizophrenia
- Recent (within past 6 months) GI hemorrhage or bleeding
- Preadmission coumadin therapy
- Cirrhosis or end stage renal disease (ESRD)
- Advanced hepatitis, AIDS, or endocarditis
- Cancer with metastases, or cancer under active treatment (chemotherapy with cytotoxic agents) other than non-melanomic skin cancers
- Current diagnosis of chronic alcohol abuse
- Preadmission narcotic use or preadmission benzodiazepine use more than 1 dose or tablet a day
- Required human assistance to walk prior to fracture
- Prior fracture
- Chest pains when climbing a flight of stairs, while walking on level ground, or at rest prior to the hip fracture
- Use of supplemental oxygen prior to fracture
- Other (Non-English speaking, severe blindness, paraplegia, hemiplegia
- Mini-Mental Status Exam score less than 20
Key Trial Info
Start Date :
October 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00390741
Start Date
October 1 1998
End Date
September 1 2005
Last Update
January 27 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Memorial Hospital
Baltimore, Maryland, United States, 21218
2
Northwest Hospital Center
Randallstown, Maryland, United States, 21133
3
St. Joseph's Hospital
Towson, Maryland, United States, 21204